Clarisa R Gracia1,2, Sanghyuk S Shin3, Maureen Prewitt4, Janna S Chamberlin3, Lori R Lofaro3, Kristin L Jones5, Marta Clendenin3, Katherine E Manzanera3, Dennis L Broyles3. 1. Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA, USA. cgracia@obgyn.upenn.edu. 2. Division of Reproductive Endocrinology, University of Pennsylvania, 3701 Market St, Suite 800, Philadelphia, PA, 19104, USA. cgracia@obgyn.upenn.edu. 3. Beckman Coulter, Inc., Carlsbad, CA, USA. 4. Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA, USA. 5. Beckman Coulter, Inc., Chaska, MN, USA.
Abstract
BACKGROUND: AMH is widely used for assessing ovarian reserve, and it is particularly convenient, because it is thought to have minimal variability throughout the menstrual cycle. However, studies assessing the stability of AMH over the menstrual cycle have been conflicting. PURPOSE: The purpose of this study is to determine whether AMH levels vary across the normal menstrual cycle. DESIGN: A multi-center, prospective cohort study conducted at three US centers. METHODS: Fifty females with regular menstrual cycles aged 18-45 underwent serial venipuncture every 3-5 days starting in the early follicular phase and lasting up to 10 collections. AMH was tested using the Access 2 immunoassay system. RESULTS: Age-adjusted mixed-effect models utilizing data from 384 samples from 50 subjects demonstrated a within subject standard deviation of 0.81 (95% CI 0.75-0.88) with a coefficient of variation of 23.8% across the menstrual cycle and between subject standard deviation of 2.56 (95% CI 2.13-3.21) with a coefficient of variation of 75.1%. Intra-class correlation (ICC) of AMH across the menstrual cycle was 0.91. CONCLUSION: Overall, AMH levels, using the automated Access AMH assay, appear to be relatively stable across the menstrual cycle. Fluctuations, if any, appear to be small, and therefore, clinicians may advise patients to have AMH levels drawn at any time in the cycle.
BACKGROUND:AMH is widely used for assessing ovarian reserve, and it is particularly convenient, because it is thought to have minimal variability throughout the menstrual cycle. However, studies assessing the stability of AMH over the menstrual cycle have been conflicting. PURPOSE: The purpose of this study is to determine whether AMH levels vary across the normal menstrual cycle. DESIGN: A multi-center, prospective cohort study conducted at three US centers. METHODS: Fifty females with regular menstrual cycles aged 18-45 underwent serial venipuncture every 3-5 days starting in the early follicular phase and lasting up to 10 collections. AMH was tested using the Access 2 immunoassay system. RESULTS: Age-adjusted mixed-effect models utilizing data from 384 samples from 50 subjects demonstrated a within subject standard deviation of 0.81 (95% CI 0.75-0.88) with a coefficient of variation of 23.8% across the menstrual cycle and between subject standard deviation of 2.56 (95% CI 2.13-3.21) with a coefficient of variation of 75.1%. Intra-class correlation (ICC) of AMH across the menstrual cycle was 0.91. CONCLUSION: Overall, AMH levels, using the automated Access AMH assay, appear to be relatively stable across the menstrual cycle. Fluctuations, if any, appear to be small, and therefore, clinicians may advise patients to have AMH levels drawn at any time in the cycle.
Authors: Wouter J K Hehenkamp; Caspar W N Looman; Axel P N Themmen; Frank H de Jong; E R Te Velde; Frank J M Broekmans Journal: J Clin Endocrinol Metab Date: 2006-06-27 Impact factor: 5.958
Authors: John F Randolph; Siobán D Harlow; Margaret E Helmuth; Huiyong Zheng; Daniel S McConnell Journal: Hum Reprod Date: 2013-12-18 Impact factor: 6.918
Authors: K A Kissell; M R Danaher; E F Schisterman; J Wactawski-Wende; K A Ahrens; K Schliep; N J Perkins; L Sjaarda; J Weck; S L Mumford Journal: Hum Reprod Date: 2014-06-12 Impact factor: 6.918
Authors: MaryFran R Sowers; Aimee D Eyvazzadeh; Daniel McConnell; Matheos Yosef; Mary L Jannausch; Daowen Zhang; Sioban Harlow; John F Randolph Journal: J Clin Endocrinol Metab Date: 2008-07-01 Impact factor: 5.958
Authors: Simone L Broer; Madeleine Dólleman; Jeroen van Disseldorp; Kimiko A Broeze; Brent C Opmeer; Patrick M M Bossuyt; Martinus J C Eijkemans; Ben Willem Mol; Frank J M Broekmans Journal: Fertil Steril Date: 2013-05-28 Impact factor: 7.329
Authors: Ilse A J van Rooij; Isolde den Tonkelaar; Frank J M Broekmans; Caspar W N Looman; Gabrielle J Scheffer; Frank H de Jong; Axel P N Themmen; Egbert R te Velde Journal: Menopause Date: 2004 Nov-Dec Impact factor: 2.953
Authors: Laura Melado; Barbara Lawrenz; Junard Sibal; Emmanuel Abu; Carol Coughlan; Alfredo T Navarro; Human Mousavi Fatemi Journal: Front Endocrinol (Lausanne) Date: 2018-11-27 Impact factor: 5.555
Authors: Hang Wun Raymond Li; David Mark Robertson; Chris Burns; William Leigh Ledger Journal: Front Endocrinol (Lausanne) Date: 2021-05-24 Impact factor: 5.555
Authors: Olesja Parmova; Eva Vlckova; Monika Hulova; Livie Mensova; Igor Crha; Petra Stradalova; Eva Kralickova; Lenka Jurikova; Martina Podborska; Radim Mazanec; Ladislav Dusek; Jiri Jarkovsky; Josef Bednarik; Stanislav Vohanka; Iva Srotova Journal: Medicine (Baltimore) Date: 2020-06-05 Impact factor: 1.817